コンテンツへスキップ
· ダーマルフィラー
SKU 11161 · GTIN 0107640173232261

Teosyal RHA 1

In stock
Volume
2 x 1 mL
Laboratory
Teoxane
Origin
スイス
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

主なメリット: Teosyal RHA 1

  • Corrects superficial fine wrinkles, skin cracks and depressions
  • Also indicated for the enhancement of skin quality and correction of withered skin on the face, neck and décolleté
  • Hyaluronic acid at 15 mg/mL, a light concentration in the RHA line
  • Degree of cross-linking below 5%, with residual BDDE below 1 ppm
  • Mean molecular weight above 1 million Dalton, of non-animal origin
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
  • Estimated duration of at least 12 months
主な情報
ブランド TEOSYAL
製造元 Teoxane SA
原産国 Switzerland
認証 CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
成分 Hyaluronic acid of non-animal origin 15 mg/mL, mean molecular weight above 1 million Dalton, cross-linked with BDDE (degree of cross-linking below 5%, residual BDDE below 1 ppm); lidocaine hydrochloride 0.3% by mass; phosphate buffer pH 7.3 q.s. ad 1 mL
容量 / サイズ 1 ml
包装 2 pre-filled syringes x 1 mL, each with 2 sterile 30G 1/2 inch needles and 2 traceability labels
使用タイプ Professional use only: injectable dermal filler with anaesthetic, for the lips, perioral, periorbital, forehead, midface, neck and décolleté regions
注入の深さ Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
プロトコル / 期間 Estimated duration of effect of at least 12 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

適応と専門的な使用

主な適応

  • Superficial fine wrinkles, skin cracks and depressions
  • Enhancement of skin quality and correction of withered skin marked by signs of ageing

専門的な使用

TEOSYAL RHA 1 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result, which is for the treating practitioner to determine.

施術部位

  • Perioral region: perioral rhytids, lips including the philtrum, oral commissures
  • Upper face: forehead lines
  • Periorbital region: crow's feet, tear trough, eyebrows
  • Midface: smiling lines and accordion lines
  • Neck lines
  • Face, neck and décolleté, for skin quality

対象となる患者

For adults assessed as suitable by the treating practitioner, typically those seeking correction of fine surface lines or an improvement in skin quality rather than added volume. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for surgery (blepharoplasty). It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

作用の仕組み: Teosyal RHA 1 ​

TEOSYAL RHA 1 works through hyaluronic acid at 15 mg/mL with a degree of cross-linking below 5%, a light, low cross-linked combination in the RHA line. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, which is what lets this grade hydrate and improve skin quality rather than build volume. The low cross-linking is the point: it keeps the gel fluid enough for superficial placement in delicate regions such as the periorbital area and neck, where a firmer gel would be visible. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.

Allparaで注文する理由

Allparaは、正規品で検証済みの TEOSYAL 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問

How does TEOSYAL RHA 1 differ from the rest of the RHA line?

Concentration and placement. Teosyal RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. Teosyal RHA 2 and Teosyal RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and Teosyal RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.

How long does TEOSYAL RHA 1 last?

The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

その他の製品: Teoxane

View laboratory

TEOXANE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.

View TEOXANE products

Clinic alternatives

All products

Teosyal RHA 1

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

TEOSYAL RHA 1 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, developed as a light filler of the RHA line. It is indicated for superficial fine wrinkles, skin cracks and depressions, and to enhance the quality of the skin. The gel contains 15 mg/mL of BDDE cross-linked hyaluronic acid with a mean molecular weight above 1 million Dalton, plus 0.3% by mass of lidocaine hydrochloride. Each box holds two pre-filled syringes, each with two sterile 30G 1/2 inch needles and two traceability labels.

主なメリット: Teosyal RHA 1

  • Corrects superficial fine wrinkles, skin cracks and depressions
  • Also indicated for the enhancement of skin quality and correction of withered skin on the face, neck and décolleté
  • Hyaluronic acid at 15 mg/mL, a light concentration in the RHA line
  • Degree of cross-linking below 5%, with residual BDDE below 1 ppm
  • Mean molecular weight above 1 million Dalton, of non-animal origin
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles and traceability labels
  • Estimated duration of at least 12 months
主な情報
ブランド TEOSYAL
製造元 Teoxane SA
原産国 Switzerland
認証 CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
成分 Hyaluronic acid of non-animal origin 15 mg/mL, mean molecular weight above 1 million Dalton, cross-linked with BDDE (degree of cross-linking below 5%, residual BDDE below 1 ppm); lidocaine hydrochloride 0.3% by mass; phosphate buffer pH 7.3 q.s. ad 1 mL
容量 / サイズ 1 ml
包装 2 pre-filled syringes x 1 mL, each with 2 sterile 30G 1/2 inch needles and 2 traceability labels
使用タイプ Professional use only: injectable dermal filler with anaesthetic, for the lips, perioral, periorbital, forehead, midface, neck and décolleté regions
注入の深さ Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
プロトコル / 期間 Estimated duration of effect of at least 12 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

適応と専門的な使用

主な適応

  • Superficial fine wrinkles, skin cracks and depressions
  • Enhancement of skin quality and correction of withered skin marked by signs of ageing

専門的な使用

TEOSYAL RHA 1 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, or onto the periosteum. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed to reach an optimal result, which is for the treating practitioner to determine.

施術部位

  • Perioral region: perioral rhytids, lips including the philtrum, oral commissures
  • Upper face: forehead lines
  • Periorbital region: crow's feet, tear trough, eyebrows
  • Midface: smiling lines and accordion lines
  • Neck lines
  • Face, neck and décolleté, for skin quality

対象となる患者

For adults assessed as suitable by the treating practitioner, typically those seeking correction of fine surface lines or an improvement in skin quality rather than added volume. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for surgery (blepharoplasty). It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

作用の仕組み: Teosyal RHA 1 ​

TEOSYAL RHA 1 works through hyaluronic acid at 15 mg/mL with a degree of cross-linking below 5%, a light, low cross-linked combination in the RHA line. Hyaluronic acid is a major constituent of the ground substance of the dermal extracellular matrix and acts as a molecular sponge, which is what lets this grade hydrate and improve skin quality rather than build volume. The low cross-linking is the point: it keeps the gel fluid enough for superficial placement in delicate regions such as the periorbital area and neck, where a firmer gel would be visible. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.

Allparaで注文する理由

Allparaは、正規品で検証済みの TEOSYAL 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。

よくある質問

How does TEOSYAL RHA 1 differ from the rest of the RHA line?

Concentration and placement. Teosyal RHA 1 carries 15 mg/mL hyaluronic acid for superficial fine lines and skin quality. Teosyal RHA 2 and Teosyal RHA 3 carry 23 mg/mL for facial wrinkles and deep creases respectively, and Teosyal RHA 4 carries 23 mg/mL for contour remodelling in thick skin areas. All four have a degree of cross-linking below 5%.

How long does TEOSYAL RHA 1 last?

The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

その他の製品: Teoxane

ラボを見る →
* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.